Login to Your Account



Pharma: Clinic Roundup


Monday, March 19, 2012
• Galderma Laboratories LP, of Fort Worth, Texas, said it completed two Phase III trials of CD07805/47, a topical gel in development for adults with moderate to severe facial erythema of rosacea.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription